Nutrien Ltd. (NTR)
NYSE: NTR · Real-Time Price · USD
70.62
-3.91 (-5.25%)
At close: Apr 17, 2026, 4:00 PM EDT
70.67
+0.05 (0.07%)
After-hours: Apr 17, 2026, 7:47 PM EDT
Nutrien Stock Forecast
Stock Price Forecast
The 22 analysts that cover Nutrien stock have a consensus rating of "Buy" and an average price target of $74.91, which forecasts a 6.07% increase in the stock price over the next year. The lowest target is $58 and the highest is $100.
Price Target: $74.91 (+6.07%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Nutrien stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 4 | 4 | 6 | 5 | 8 | 8 |
| Hold | 10 | 10 | 11 | 11 | 9 | 9 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 2 | 2 |
| Total | 17 | 17 | 20 | 19 | 22 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $77 → $93 | Buy | Maintains | $77 → $93 | +31.69% | Apr 8, 2026 |
| UBS | UBS | Hold → Strong Sell Downgrades $63 → $67 | Hold → Strong Sell | Downgrades | $63 → $67 | -5.13% | Mar 26, 2026 |
| B of A Securities | B of A Securities | Hold Maintains $75 → $81 | Hold | Maintains | $75 → $81 | +14.70% | Mar 18, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $85 → $90 | Buy | Maintains | $85 → $90 | +27.44% | Mar 18, 2026 |
| CIBC | CIBC | Buy Maintains $81 → $90 | Buy | Maintains | $81 → $90 | +27.44% | Mar 17, 2026 |
Financial Forecast
Revenue This Year
26.99B
from 25.95B
Increased by 4.03%
Revenue Next Year
26.69B
from 26.99B
Decreased by -1.11%
EPS This Year
5.62
from 4.66
Increased by 20.64%
EPS Next Year
5.07
from 5.62
Decreased by -9.89%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 29.6B | 29.5B | |||
| Avg | 27.0B | 26.7B | |||
| Low | 25.0B | 24.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 14.1% | 9.3% | |||
| Avg | 4.0% | -1.1% | |||
| Low | -3.7% | -8.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 14.00 | 7.79 | |||
| Avg | 5.62 | 5.07 | |||
| Low | 4.26 | 3.57 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 200.4% | 38.6% | |||
| Avg | 20.6% | -9.9% | |||
| Low | -8.5% | -36.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.